EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children

Maodong Leng, Junmei Yang, Juanjuan Zhou

Frontiers in Pediatrics · 02.03.2023 · 11

DOI: 10.3389/fped.2023.1115009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pediatrics, online erschienen am 02.03.2023. Verfasst von Maodong Leng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study is to review the molecular characteristics, the diagnosis, and treatment of the widespread infection of macrolide-resistant Mycoplasma pneumoniae ( M. pneumoniae ; MRMP) in children, thus providing a better knowledge of this infection and presenting the associated problems. Single point mutations in the V region of the 23S rRNA gene of M. pneumoniae genome are associated with macrolide resistance. P1–1, MLVA4-5-7-2, and ST3 are usually the predominated genetic types in the M. pneumoniae epidemics. The short-term two times serological IgM (or together with IgG) test in the acute stage can be used for confirmation. Combined serological testing and PCR might be a more prudent method to reduce macrolide consumption and antibiotic selective pressure in a clinical setting. Molecular methods for the detection of single-nucleotide mutations in the V region of the 23S rRNA gene can be used for the diagnosis of MRMP. The routine use of macrolide for the treatment of macrolide-sensitive Mycoplasma pneumoniae (MSMP) infections can get good effect, but the effects are limited for severe MRMP infections. Additional corticosteroids may be required for the treatment of severe MRMP infections in children in China during the era of MRMP.

Schlagwörter

Stichwörter der Autor:innen

Mycoplasma pneumoniaediagnosisgenotypemacrolide resistancetreatment

Autor:innen und Institutionen

  • Zhengzhou Key Laboratory of Children's Infection and Immunity, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, China.

Zitieren

APA

Leng, M., Yang, J., & Zhou, J. (2023). The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1115009

Vancouver

Leng M, Yang J, Zhou J. The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1115009

BibTeX
@article{Leng2023,
  author = {Leng, Maodong and Yang, Junmei and Zhou, Juanjuan},
  title = {The molecular characteristics, diagnosis, and treatment of macrolide-resistant Mycoplasma pneumoniae in children},
  journal = {Frontiers in Pediatrics},
  year = {2023},
  volume = {11},
  doi = {10.3389/fped.2023.1115009}
}
Kostenlos starten →